ArticleFrontiers in chemistry2025
Antibacterial effects of coniferyl alcohol-derived dehydrogenation polymer on chlamydial infection
Article in Frontiers in chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Lignin/alginate biomaterials as a promising complementary approach in ocular chlamydial infection.Frontiers in cellular and infection microbiology · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Material and Methods: The cytotoxicity of DHP/Alg on A2EN genital epithelial cells was assessed by measuring cell viability. To investigate its effects on Results: No cytotoxic effects of DHP/Alg in tested concentrations on A2EN cells were observed, confirming its safety. Infection and adhesion assays demonstrated a significant reduction in infection levels, suggesting that DHP/Alg directly targets Conclusion: Our results suggest that DHP/Alg is a promising therapeutic option against chlamydial infections. The significant reduction in adhesion levels indicates that DHP/Alg effectively interferes with the initial stages of infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.